You can find the list of participating centers from list of trials. Once you contact the nearest center they will tell you who are the participating physicians. You might be cutting it close, typically NYMX announces the results before their shareholder meeting which is next Friday.
The good doctor couldn't care less about your letter.
In case you have not figured it out this is a shell company with the good doctor and LG owning about 90% of the company. The majority of public shareholders are mostly uneducated, naïve and clueless cheerleaders.The doctor does the minimum necessary to maintain the fig leaf of being a public company.
I am not even sure why this company is public.
The stock will go up regardless if the results are good with the Dr. and LG collecting the vast share of the loot. The public shareholders will also get their crumbs.
The only reason LG and the doctor are in this stock because they will become rich from this. There is no other reason for LG to be involved otherwise.
I agree with you, although I have a significant long position, its the sheer stupidity , ignorance and bullying tactics aka cowardice of the longs here that worries me the most about this stock. I really do not want to be long a stock that these people are long but what can you do.
Expect Interim Results of Second Reinjection Study in A Few Weeks.
Its a good joke; NYMX should have a comedy club gig; this is exactly what they said on May 8th announcement of the BPH trials completion.
May 8 th to July 15 th is over two months and ten weeks; not a few weeks.
For most native English speakers expeditiously and few weeks amount to the same thing. Stop quibbling and posting meaningless drivel!
Based on the number of posts from you every day I assume you either have no job or this is your job where you get paid per post. The other possibility of is you are a retired village idiot who gets off by trying to intimidate people on an annonymous stock board .
When you talked to Dr. Shore I understand he was not convinced the needle might be the best approach but did he think the drug worked and if so better/worse than medications?
The reason he said this was because he is now touting an alternative BPH treatment (See below) which does not involve needles.. He is a paid consultant; he endorses whatever procedure he is currently performing. I am glad he did not put down NX 1207 for any other reason. Your honesty is appreciated. Thanks.
Click here for an article on sexual function and BPH by Neal D. Shore, MD, Myrtle Beach, South Carolina. Dr. Shore is a clinical urologist and principle investigator of the Prolieve Thermodilatation® System, who specializes in prostate disease and has performed more than 200 office-based minimally invasive treatments for the symptoms of BPH. This article is based on Dr. Shore's clinical experiences and opinions. Dr. Shore is a paid consultant of Boston Scientific.
All the pills for BPH have significant side effects especially in this age group. I think I would infinitely prefer an injection every couple of years but we will find out- hopefully soon. Ultimately this is a gamble. Both the detractors and the cheerleaders are speculating/gambling but FWIW my money is on NX1207
That statement was true ten years ago. Flomax the currently used drug is reported to show a mean improvement of 9.7 at the 0.8 mg dose and 9.4 at the 0.4 mg dose.
This is the end of the third month, not second month.
Secondly Dr. A was unequivocal in his assertion that results of first phase three would be released in 2013.
FROM THE NYMOX WEBSITE
Nymox Announces Completion of Patient Enrollment in Pivotal U.S. Phase 3 BPH Study
Topic: R&D: BPH (enlarged prostate) Treatments
November 28, 2012: Nymox announced today completion of patient enrollment in the Company’s pivotal U.S. Phase 3 NX02-0017 Study of NX-1207 for BPH. This study is now closed to further enrollment. Top-line results from the large Phase 3 Study are expected in late 2013.
You are wrong about it being 96% retail. Yahoo and other sites are not accurate for this. I would guess Doc owns about 40-50% of the company and other insiders principally a shady hedge fund/banker from Panama/Switzerland own around 30%. If you dig into LG funds history they have a history of backing such enterprises; their other major investment that I know of is a mine in S. America.
This is why Dr. A cares a fig about shareholders; his principal means of finance is LG.
Not necessary if LG is a collection of individual and each owns less than 5% ( they can even split it among family members). From my research it appears LG is a group of wealthy individuals who collectively invest in projects. Look at the volume of this stock, there is no volume to support your hypothesis that they sell after 60-90 days and who is then buying the stock? If LG I selling no amount of retail interest would keep the stock price stable.
I never said its a proper or legit group. Look at their investments. I agree research on them is hard to do; I got access to more information by the way back machine two or three years back.
Shorting a five dollar stock is peanuts for them; they have poured millions into the co. over years.
I bought the majority of shares sold today, A selling his shares is just noise. I would like to know when he sold his shares though; anyone have a clue?
The phraseology of the letter suggests they were referring to an event in the past. I was wondering what was the time limit on this reporting ie how long do they have (after they sell) before they have to report.
Nothing wrong with my mood :) Thank you for asking.
I was looking at this.
MONTREAL, Aug. 6, 2014 (GLOBE NEWSWIRE) -- This press release is being disseminated as required by the early warning requirements of applicable securities laws. Paul Averback MD announces today that he has sold in a private transaction for financial planning purposes 470,600 common shares of Nymox Pharmaceutical Corporation ("Nymox") for a total consideration of US $2,400,000 ($2,622,240 CDN). This sale represents 1.3% of the shares of Nymox issued and outstanding. As a result of this sale, Dr. Averback continues to own and control 10,931,448 shares of Nymox or approximately 31% of the shares of Nymox issued and outstanding.
This announces he has sold but gives no information as to when he sold. Since this is dated August 6, 2014; I assume the transaction happened earlier but I see you are thinking the date of the announcement is the same as the date they were sold. Hmm.....This would imply that the results are not going to be released soon.
Flomax costs around $ 3000 a year,most likely nymox will be priced in this price range and will surely be approved by insurances as its also more cost effective for them. Another way to value this is look at companies with a similar single succesfull product and see their marketcap; Allergan would be a good example.